HRP20151308T1 - Antibakterijski derivati kinolina - Google Patents
Antibakterijski derivati kinolina Download PDFInfo
- Publication number
- HRP20151308T1 HRP20151308T1 HRP20151308TT HRP20151308T HRP20151308T1 HR P20151308 T1 HRP20151308 T1 HR P20151308T1 HR P20151308T T HRP20151308T T HR P20151308TT HR P20151308 T HRP20151308 T HR P20151308T HR P20151308 T1 HRP20151308 T1 HR P20151308T1
- Authority
- HR
- Croatia
- Prior art keywords
- methyl
- phenyl
- quinolin
- benzyl
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05106962 | 2005-07-28 | ||
| PCT/EP2006/064656 WO2007014885A1 (en) | 2005-07-28 | 2006-07-26 | Antibacterial quinoline derivatives |
| EP06777972.8A EP1912948B1 (en) | 2005-07-28 | 2006-07-26 | Antibacterial quinoline derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20151308T1 true HRP20151308T1 (hr) | 2016-01-01 |
Family
ID=35610159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20151308TT HRP20151308T1 (hr) | 2005-07-28 | 2006-07-26 | Antibakterijski derivati kinolina |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US7915292B2 (enExample) |
| EP (1) | EP1912948B1 (enExample) |
| JP (1) | JP5100647B2 (enExample) |
| KR (1) | KR101334719B1 (enExample) |
| CN (1) | CN101273016B (enExample) |
| AP (1) | AP2322A (enExample) |
| AR (1) | AR054587A1 (enExample) |
| AU (1) | AU2006274918B2 (enExample) |
| BR (1) | BRPI0614122B8 (enExample) |
| CA (1) | CA2614981C (enExample) |
| CY (1) | CY1117247T1 (enExample) |
| DK (1) | DK1912948T3 (enExample) |
| EA (1) | EA015617B1 (enExample) |
| ES (1) | ES2554924T3 (enExample) |
| HR (1) | HRP20151308T1 (enExample) |
| HU (1) | HUE026259T2 (enExample) |
| IL (1) | IL188987A0 (enExample) |
| JO (1) | JO3077B1 (enExample) |
| MX (1) | MX2008001219A (enExample) |
| MY (1) | MY148219A (enExample) |
| NO (1) | NO341795B1 (enExample) |
| NZ (1) | NZ565946A (enExample) |
| PL (1) | PL1912948T3 (enExample) |
| PT (1) | PT1912948E (enExample) |
| RS (1) | RS54382B1 (enExample) |
| SI (1) | SI1912948T1 (enExample) |
| TW (1) | TWI427065B (enExample) |
| UA (1) | UA94051C2 (enExample) |
| WO (1) | WO2007014885A1 (enExample) |
| ZA (1) | ZA200800783B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080076924A1 (en) * | 2006-06-30 | 2008-03-27 | Patrick Betschmann | Piperazines as P2X7 antagonists |
| WO2011144444A1 (en) * | 2010-05-21 | 2011-11-24 | Syngenta Participations Ag | Novel amides as fungicides |
| AU2013254670B2 (en) | 2012-04-27 | 2017-03-30 | Janssen Pharmaceutica Nv | Antibacterial quinoline derivatives |
| ES2576491T3 (es) | 2012-04-27 | 2016-07-07 | Janssen Pharmaceutica, N.V. | Derivados de quinolina antibacterianos |
| ES2596243T3 (es) * | 2012-08-24 | 2017-01-05 | F. Hoffmann-La Roche Ag | Nuevos derivados bicíclicos de piridina |
| CN104650054B (zh) * | 2013-11-25 | 2019-09-13 | 重庆医药工业研究院有限责任公司 | 一种抗结核菌的喹啉噻吩芳氧乙胺衍生物 |
| CN105175329B (zh) * | 2014-06-10 | 2017-09-19 | 重庆圣华曦药业股份有限公司 | 一种贝达喹啉消旋体的合成路线及方法 |
| US20190321324A1 (en) * | 2016-12-30 | 2019-10-24 | Board Of Regents, The University Of Texas System | Quaternary amine antibiotic therapeutics |
| CN110804016B (zh) * | 2019-12-05 | 2022-11-04 | 福建省微生物研究所 | 抗结核分枝杆菌的二芳基喹啉衍生物 |
| US20240287022A1 (en) * | 2021-06-28 | 2024-08-29 | Merck Sharp & Dohme Llc | Il4i1 inhibitors and methods of use |
| CN117843568A (zh) * | 2024-01-03 | 2024-04-09 | 中国药科大学 | 一种芳烷基取代-1-甲基喹啉季铵盐类衍生物及其制备方法和用途 |
| CN119666810A (zh) * | 2025-02-19 | 2025-03-21 | 吉林国际旅行卫生保健中心(长春海关口岸门诊部) | 基于图像处理的舌拭子样本荧光检测结核分歧杆菌的方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1041035A3 (ru) * | 1982-02-25 | 1983-09-07 | Киорин Сейяку Кабусики Кайся (Фирма) | Способ получени производных хинолинкарбоновой кислоты,их гидратов или солей |
| JPS6463518A (en) * | 1987-09-02 | 1989-03-09 | Otsuka Pharma Co Ltd | Antiarrhythmic agent |
| US5235054A (en) * | 1992-07-15 | 1993-08-10 | Pfizer Inc. | 3-carboxaldehyde substituted quinolines and naphthyridines |
| DE69518075T2 (de) * | 1994-05-24 | 2001-03-22 | F. Hoffmann-La Roche Ag, Basel | Tricyclische dicarbonylderivate |
| CN1307565A (zh) * | 1998-04-29 | 2001-08-08 | 史密丝克莱恩比彻姆有限公司 | 用作mrs抑制剂和杀菌剂的喹诺酮化合物 |
| SI1527050T1 (sl) | 2002-07-25 | 2010-08-31 | Janssen Pharmaceutica Nv | Kinolinski derivati in njihova uporaba kot mikobakterijski inhibitorji |
-
2006
- 2006-07-11 JO JOP/2006/0218A patent/JO3077B1/ar active
- 2006-07-26 WO PCT/EP2006/064656 patent/WO2007014885A1/en not_active Ceased
- 2006-07-26 MY MYPI20063590A patent/MY148219A/en unknown
- 2006-07-26 HU HUE06777972A patent/HUE026259T2/en unknown
- 2006-07-26 HR HRP20151308TT patent/HRP20151308T1/hr unknown
- 2006-07-26 BR BRPI0614122A patent/BRPI0614122B8/pt not_active IP Right Cessation
- 2006-07-26 DK DK06777972.8T patent/DK1912948T3/en active
- 2006-07-26 SI SI200631998T patent/SI1912948T1/sl unknown
- 2006-07-26 US US11/996,786 patent/US7915292B2/en active Active
- 2006-07-26 UA UAA200800826A patent/UA94051C2/ru unknown
- 2006-07-26 CA CA2614981A patent/CA2614981C/en not_active Expired - Lifetime
- 2006-07-26 NZ NZ565946A patent/NZ565946A/en not_active IP Right Cessation
- 2006-07-26 EA EA200800455A patent/EA015617B1/ru unknown
- 2006-07-26 ES ES06777972.8T patent/ES2554924T3/es not_active Expired - Lifetime
- 2006-07-26 JP JP2008523352A patent/JP5100647B2/ja not_active Expired - Fee Related
- 2006-07-26 MX MX2008001219A patent/MX2008001219A/es active IP Right Grant
- 2006-07-26 KR KR1020087004457A patent/KR101334719B1/ko not_active Expired - Fee Related
- 2006-07-26 CN CN200680035175XA patent/CN101273016B/zh not_active Expired - Fee Related
- 2006-07-26 RS RS20150796A patent/RS54382B1/sr unknown
- 2006-07-26 PL PL06777972T patent/PL1912948T3/pl unknown
- 2006-07-26 AU AU2006274918A patent/AU2006274918B2/en not_active Ceased
- 2006-07-26 AP AP2008004308A patent/AP2322A/xx active
- 2006-07-26 EP EP06777972.8A patent/EP1912948B1/en not_active Expired - Lifetime
- 2006-07-26 PT PT67779728T patent/PT1912948E/pt unknown
- 2006-07-27 TW TW095127409A patent/TWI427065B/zh not_active IP Right Cessation
- 2006-07-27 AR ARP060103260A patent/AR054587A1/es unknown
-
2008
- 2008-01-24 IL IL188987A patent/IL188987A0/en active IP Right Grant
- 2008-01-25 ZA ZA200800783A patent/ZA200800783B/xx unknown
- 2008-02-27 NO NO20081008A patent/NO341795B1/no not_active IP Right Cessation
-
2015
- 2015-12-08 CY CY20151101113T patent/CY1117247T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20110392T1 (hr) | Derivati kinolina za liječenje latentne tuberkuloze | |
| HRP20160585T1 (hr) | Antibakterijski derivati kinolina | |
| EA200800815A1 (ru) | 2-анилин-4-арилзамещенные тиазольные производные | |
| HRP20131116T1 (hr) | Derivati kinolina kao antibakterijska sredstva | |
| HRP20141190T1 (hr) | Disupstituirani derivati piridina kao antikancerogena sredstva | |
| ME01421B (me) | 5-supstituisani derivati kinazolinona kao protivtumorska sredstva | |
| JP2012224649A5 (enExample) | ||
| HRP20201171T1 (hr) | Derivati izoindolin-1-ona kao modulatori aktivnosti pozitivnog alosternog modulatora kolinergijskog muskarinskog m1 receptora za liječenje alzheimerove bolesti | |
| CA2478229A1 (en) | Pyridinoylpiperidines as 5-ht1f agonists | |
| HRP20160824T2 (hr) | Derivati benzotiofena supstituirani piperazinom kao antipsihotički agensi | |
| AR064153A1 (es) | Derivados de quinolina antibacterianos. procesos de obtencion y composiciones farmaceuticas. | |
| AR045083A1 (es) | Productos aril-heteroaromaticos, composiciones que los contienen y utilizacion como medicamento | |
| HRP20220414T1 (hr) | Inhibitori lizin specifične demetilaze-1 | |
| JP2016507502A5 (enExample) | ||
| NZ603724A (en) | Piperidine derivatives and their use for the treatment of metabolic disorders | |
| HRP20120510T1 (hr) | Derivati beta amino kiseline za liječenje dijabetesa | |
| HRP20120919T1 (hr) | 2-[4-(pirazol-4-ilalkil)piperazin-1-il]-3-fenilpirazini i -piridini i 3-[4-(pirazol-4-ilalkil)piperazin-1-il]-2-fenilpiridini kao antagonisti receptora 5-ht7 | |
| MX2014005635A (es) | Derivados de 2 - (1,2,3 -triazol - 2 - il) benzamida y 3 - (1,2,3 - triazol - 2 - il) picolinamida. | |
| HRP20140588T1 (hr) | Spojevi kondenziranog prstena i njihova uporaba | |
| JP2009502869A5 (enExample) | ||
| ME01245B (me) | Antibakterijski hinolinski derivati | |
| HRP20161286T1 (hr) | Novi anti-invazivni spojevi | |
| AR054587A1 (es) | Derivados de quinolina antibacterianos | |
| ATE388939T1 (de) | N-((piperazinyl)hetaryl)arylsulfonamid-derivate mit affinität zum dopamin-d3-rezeptor | |
| AR064417A1 (es) | Sal succinato de 2-((4-(1-metil-4-(piridin-4-il)-1h-pirazol-3-il)fenoxi)metil)metil)quinolina composiciones farmaceuticas que la contienen y usos para el tratamiento de trastornos del snc |